We consider the problem of assessing new and existing technologies for their cost-effectiveness in the case where data on both costs and efficacy are available from a clinical trial, and we address it by means of the cost-effectiveness acceptability curve in the simple case where efficacy is...

We consider the problem of assessing new and existing technologies for their cost-effectiveness in the case where data on both costs and effects are available from a clinical trial, and we address it by means of the cost-effectiveness acceptability curve. The main difficulty in these analyses is...